Radar Telegram alerts Open Radar

The Hungarian pharmaceutical company Gideon Richter has agreed to acquire the Australian Maine Pharma for 604 million Australian dollars (about 407.8 million US dollars), reports Reuters. The buyer offered A$6.40 per share, a 99.4% premium to the previous close, sending Maine's share price up 86% to a one-year high. The deal is subject to regulatory approval and the completion of the sale of Maine's international business to Auris Pharma.

תרגם לעברית

Кролик с Неглинной · · Source

🇺🇸 USA · Map

The Hungarian pharmaceutical company Gideon Richter has agreed to acquire the Australian Maine Pharma for 604 million Australian dollars (about 407.8 million US dollars), reports Reuters. The buyer offered A$6.40 per share, a 99.4% premium to the previous close, sending Maine's share price up 86% to a one-year high. The deal is subject to regulatory approval and the completion of the sale of Maine's international business to Auris Pharma.

More on Radar

Want to see every report in real time?

Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.

Sign up free
Share on WhatsApp Get alerts on Telegram